Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

NewsGuard 100/100 Score

"Speaking out against a potential $16 million cut in the Army's base research and development budget  for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter (.pdf) Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog. In the letter, IDSA President James Hughes and HIVMA Board Chair Kathleen Squires "urged the secretary ... to continue the modest investment in the MHRP, which also sustains more than 100,000 HIV-infected people in Kenya, Tanzania, Uganda, Nigeria, Mozambique and Thailand on lifesaving antiretroviral therapy through the [PEPFAR] program," the blog writes (10/13).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New drug candidates show promise to reverse HIV immune evasion